NCAM1 and breast carcinoma: Therefore, to gain insight into the status of CD56 in breast cancer tissues, we analyzed the expression of this protein by IHC in 99 patient-derived breast cancer tissues and revealed high inter- and intratumoral heterogeneity regarding CD56 expression.